The Definitive Guide to Exporting Dietary Supplements to the United States: Comprehensive FDA & FTC Compliance Manual

The United States represents the largest and most lucrative consumer market for dietary supplements and wellness products globally. For international brands, expanding into the U.S. market offers extraordinary commercial potential. However, entering this territory requires navigating a rigorous, highly specialized regulatory landscape overseen primarily by two federal agencies: the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC)

A common and costly misconception among foreign manufacturers is that dietary supplements can be imported into the U.S. with standard customs declarations or simple food facility registrations. In reality, imported supplements face meticulous scrutiny at ports of entry. Failure to comply with strict federal requirements concerning ingredient legality, pre-market notifications, labeling formatting, substantiation of claims, and supply-chain verification can lead to immediate border detentions, placement on Import Alerts, mandatory re-exportation, or complete destruction of inventory.

This comprehensive compliance manual serves as a master blueprint for international manufacturers, brand owners, and export managers. It details the precise regulatory requirements necessary to establish a legal, compliant, and uninterrupted distribution pipeline into the United States.

1. The Legal Framework: Understanding DSHEA, the FDA, and the FTC

The regulation of dietary supplements in the United States is uniquely structured. Unlike pharmaceutical drugs, which require pre-market approval from the FDA based on clinical safety and efficacy data, dietary supplements operate under a post-market enforcement model established by a landmark piece of federal legislation: the Dietary Supplement Health and Education Act of 1994 (DSHEA).

The Role of DSHEA

DSHEA amended the Federal Food, Drug, and Cosmetic Act to establish a distinct regulatory category for dietary supplements. Under DSHEA, a dietary supplement is legally defined as a product taken by mouth that contains a “dietary ingredient” intended to supplement the diet. These ingredients may include:

• Vitamins and minerals
• Botanicals, herbs, and plant extracts
• Amino acids
• Enzymes, glandular extracts, organ tissues, or metabolites

Crucially, DSHEA shifts the burden of proof. The FDA does not review or clear dietary supplements for safety or effectiveness before they hit the market, nor does it pre-approve their labels. Instead, the legal responsibility for ensuring product safety, manufacturing quality, and label accuracy rests entirely on the manufacturer, distributor, and brand owner. The FDA’s role is primarily post-market enforcement—monitoring the marketplace and border entries, and taking swift legal action against products found to be adulterated, misbranded, or unsafe.

The Dual-Agency Oversight

While the FDA handles the safety, formulation, manufacturing controls, and labeling of dietary supplements, the FTC exercises concurrent jurisdiction over advertising and marketing.

• The FDA Focus: Formulations, ingredient legality, labeling mechanics (the Supplement Facts panel), manufacturing facility registrations, and mandatory product warnings.
• The FTC Focus: Advertising copy, digital marketing funnels, website product descriptions, social media campaigns, influencer endorsements, and consumer testimonials. The FTC mandates that all advertising must be truthful, non-misleading, and supported by rigorous scientific evidence before a claim is made public.

For international companies, this means your compliance strategy must be synchronized. A product with a flawlessly compliant physical label can still be heavily penalized by the FTC if the companion website or Instagram marketing campaign contains unlawful health representations

Phase 1: Formula and Ingredient Compliance Review

The foundational stage of any U.S. market entry strategy begins with an exhaustive scientific audit of the product’s precise quantitative formulation. This step must be executed prior to manufacturing packaging materials, investing in raw materials, or arranging shipping logistics.

Active Dietary Ingredients vs. Passive Excipients

The FDA evaluates every single component of a dietary supplement formula independently. A compliance review must account for two distinct categories within the formula:

1. Active Dietary Ingredients: These are the primary substances intended to deliver the product’s nutritional or physiological benefits (e.g., specific vitamins, standardized botanical extracts, target amino acids).
2. Excipients and Processing Aids: These are the passive substances used to manufacture the delivery form (e.g., flow agents, binders, artificial colors, flavorings, sweeteners, chemical preservatives, capsule shell materials, and glazes).

Every ingredient must be quantified down to its exact milligram or percentage concentration per serving to assess its legal status and safety profile.

For products containing herbs, traditional medicines, or botanical blends, the FDA demands absolute scientific precision regarding identity and nomenclature. A standard trade name or common local name is insufficient. The regulatory dossier must provide:

• The exact botanical Latin binomial(including genus, species, and authority, where applicable).
• The precise plant part utilized(e.g., root, leaf, aerial parts, seed, bark), as different parts of the same plant can have radically different biochemical profiles, toxicity levels, and legal statuses.
• The extract ratiostandardization parametersidentifying target active marker compounds (e.g., standardized to 25% anthocyanins).

Identifying Red Flags and Compliance Gaps

During an ingredient legality review, several potential pitfalls must be checked against active FDA databases, warning letters, and import alerts:

• Non-Qualifying Substances: Ingredients that do not meet the statutory definition of a dietary ingredient under DSHEA (e.g., certain synthetic compounds or industrial chemicals).
• Active FDA Import Alerts: Check if any ingredient in the formula is currently subject to an active Import Alert (such as Import Alert 66-41 for unapproved new drugs, or alerts targeting specific contaminated botanicals).
• Conditions of Use Restrictions: Certain ingredients are permitted only within highly specific parameters or daily dosage thresholds. Exceeding these limits shifts the product into an adulterated category.
• The Food-vs.-Drug Boundary: If an ingredient has been intensely studied or approved as a prescription drug in the United States prior to being widely marketed as a dietary supplement or food, the FDA may enforce the “drug preclusion” clause. This clause legally bars the substance from being sold as a dietary supplement.

Phase 2: The New Dietary Ingredient (NDI) Landmine

One of the most common reasons international supplement shipments face immediate border detention is a failure to navigate the New Dietary Ingredient (NDI) notification framework. This represents a complex and highly technical aspect of U.S. supplement law.

Defining an NDI

Under section 413(d) of the Federal Food, Drug, and Cosmetic Act, a New Dietary Ingredient is defined as any dietary ingredient that was not marketed in the United States as a dietary supplement before October 15, 1994

Any ingredient that was commercially distributed in the U.S. prior to this cutoff date is considered an “Old Dietary Ingredient” or a “grandfathered” ingredient. Grandfathered ingredients are permitted for use without a pre-market notification to the FDA, provided they have not been chemically altered from their historic form.

The 75-Day Pre-Market Notification Requirement

If an international brand formulates a supplement containing an NDI, and an applicable legal exemption cannot be documented, the manufacturer or distributor must submit a formal NDI notification to the FDA at least 75 days before introducing the product into U.S. interstate commerce.

The NDI notification is not a simple form. It is a highly technical, extensive safety dossier that must compile:

• Rigorous toxicological data, history of use, or peer-reviewed clinical studies.
• Comprehensive evidence demonstrating that the dietary supplement containing the NDI will reasonably be expected to be safe under the conditions of use recommended or suggested in the labeling.
• A full breakdown of the manufacturing process, specifications, and identity testing protocols used to ensure batch-to-batch consistency.

Determining NDI Status

When a brand intends to utilize an ingredient, a preliminary assessment must be conducted to establish its regulatory history. This involves reviewing independent grandfathered ingredient lists (such as those compiled by trade associations like the American Herbal Products Association) and checking historical FDA NDI response logs.

If your formula contains a novel extract, an engineered molecule, or a botanical that has only been consumed traditionally outside of the United States, you must be prepared to either adjust your formulation or execute the full, separate 75-day FDA submission process before exporting your cargo.

Phase 3: Supplement Facts Panel Engineering

In the United States, the nutrition label for a dietary supplement is legally designated as the Supplement Facts panel. The design, layout, font sizes, and ordering of elements within this panel are governed by highly prescriptive regulations under 21 CFR Section 101.36

Foreign brands cannot simply use the nutrition label formatting required by their home country (such as the EU Nutrition Declaration or Latin American front-of-pack patterns). The panel must be engineered from scratch using your quantitative formula data.

Mandatory Components of a U.S. Supplement Facts Panel

A fully compliant U.S. Supplement Facts panel must strictly incorporate the following structural elements

 

1. Serving Size: This must be based on the maximum amount recommended for consumption at any one time. It must be expressed in common household measures (e.g., 1 Tablet, 2 Capsules, 1 Scoop) followed by the metric equivalent.
2. Serving Per Container: The total number of servings present in the complete package volume based on the serving size.
3. The “Line” Ingredients (Vitamins, Minerals, Electrolytes): If vitamins, minerals, or essential nutrients are present in significant amounts, they must be declared using their specific required names and forms (e.g., “Vitamin C (as Ascorbic Acid)”).
4. Amounts Per Serving: The precise quantitative metric weight of each active ingredient delivered per individual serving.
5. Percent Daily Value (% DV) Declarations: You must calculate and declare the exact percentage of the U.S. Daily Value for all nutrients where a federal reference standard exists, rounded according to strict regulatory rules.
6. Ingredients Without Established Daily Values: For botanicals, specialized compounds, or amino acids that do not have an officially established U.S. reference value, a column or footnote must explicitly display an asterisk linking to the statement *Daily Value (DV) not established.

Rules for Proprietary Blends

If your formula utilizes a proprietary blend to protect your intellectual property, you are permitted to hide the individual milligram amounts of the specific ingredients within that blend. However, you must comply with strict disclosure rules:

• The blend must be given a unique name and the total collective metric weight of the entire blend must be stated.
• Every single ingredient within the proprietary blend must be listed in strict descending order of predominance by weight
• No individual ingredient weights can be disclosed selectively; it is an all-or-nothing regulatory framework.

The “Other Ingredients” Statement and Allergen Disclosures

Directly below the Supplement Facts box, the manufacturer must place the Other Ingredients statement. This list must contain all excipients, capsules, binders, and processing aids, formatted in descending order of weight. Furthermore, the product must comply with the Food Allergen Labeling and Consumer Protection Act (FALCPA) by clearly disclosing the presence of any major U.S. allergens (e.g., milk, eggs, fish, crustacean shellfish, tree nuts, wheat, peanuts, soybeans, and sesame).

Phase 4: Complete Dietary Supplement Label Review

Beyond the Supplement Facts panel, the entire physical packaging layout—including the front panel, side panels, back panels, and any enclosed leaflets—must be structurally audited against the five fundamental label statements mandated by the FDA.

The 5 Fundamental Label Statements

The FDA requires that five distinct pieces of information be prominently displayed on a supplement package, positioned on specific panels and formatted to meeting precise font height constrains

Language and Country-of-Origin Mechanics

• English Language Mandate: All required label statements must appear clearly in the English language. If a package displays any foreign language text anywhere on the container, every single required regulatory statement must be fully duplicated in that foreign language> as well.
• Country of Origin: Under U.S. Customs (CBP) regulations, the container must conspicuously display the country of origin in a clear, unambiguous format (e.g., “Product of India”, “Made in Spain”) near the manufacturer statement.

The Mandatory DSHEA Disclaimer

If your supplement packaging displays any health-related claims regarding the product’s physiological effects, the FDA legally enforces the mandatory placement of the DSHEA Disclaimer. This disclaimer consists of two specific sentences that must be enclosed in a clear border box, formatted in bold type, and positioned adjacent to the claims without any intervening text:

“This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

Phase 5: Navigating the FDA vs. FTC Claims Boundary

The words, imagery, and testimonials used to market your dietary supplement represent the highest area of risk for regulatory enforcement actions. The FDA and FTC collaborate to aggressively police unpermitted claims, classifying non-compliant products as unapproved new drugs or misbranded supplements.

Structure/Function Claims vs. Prohibited Disease Claims

Under DSHEA, dietary supplement marketers are legally restricted to using Structure/Function claims or general wellness representations. They are completely prohibited from making Disease claims.

• Permissible Structure/Function Claims: These describe the role of a nutrient or dietary ingredient intended to affect the normal structure or function of the human body.
  • Examples: “Supports a radiant skin complexion,” “Promotes joint flexibility,” “Helps maintain healthy energy levels”.
• Prohibited Disease Claims: Any claim that explicitly or implicitly represents that a product can diagnose, mitigate, treat, cure, or prevent a specific human disease, deformity, or abnormal physical state.

If a supplement makes a disease claim on its label, its website, or its social media ads, the FDA legally reclassifies the product as a drug. Because it lacks pre-market pharmaceutical approval, it is instantly deemed an unapproved new drug, rendering it illegal to import or sell in the United States.

The 30-Day FDA Notification Rule

When an international company launches a supplement in the U.S. utilizing a structure/function claim, the brand owner must submit a formal Structure/Function Claim Notification to the FDA within 30 days of the product’s first commercial marketing. This administrative filing updates the FDA’s database regarding your active marketing representations.

The FTC Standard of Scientific Substantiation

While the FDA tracks the legal definition of the words used, the FTC focuses on consumer protection and truth-in-advertising. Under the FTC Act, you cannot make a health claim unless you possess competent and reliable scientific evidence to substantiate that the claim is true.

The FTC evaluates marketing using several rigid parameters:

• Implied Claims: The FTC looks at the entire context of your marketing funnel. If your text uses a valid structure/function claim, but your website displays imagery of medical equipment, before-and-after photos of skin pathologies, or doctor testimonials, the FTC will rule that you are making an implied disease claim.
• Consumer Testimonials: You cannot use a customer review to make a claim that you could not legally make yourself. If a user posts on your site: “This supplement cured my psoriasis!” and you use that testimonial in your promotional materials, you are legally liable for making an un-substantiated disease claim.

Phase 6: Manufacturer Quality and Documentation Audit

An international brand must ensure that its contract manufacturing facility—whether located in China, India, Europe, or South America—fully complies with the FDA’s specialized Current Good Manufacturing Practice (cGMP) regulations outlined in 21 CFR Part 111.

During border inspections, the FDA frequently detains shipments not because of a label error, but because the foreign factory cannot produce the rigorous quality documentation demanded by federal inspectors. Prior to exportation, a thorough document-based audit must verify the availability and accuracy of the following technical assets:

1. Master Manufacturing Records (MMR)

The factory must possess an official Master Manufacturing Record for every unique formulation and batch size. The MMR acts as the exact, standardized “recipe” for production, specifying:

• The exact specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.
• Precise instructions for manual or automated additions of ingredients, mixing times, temperatures, and equipment settings.
• Detailed packaging and labeling specifications, including descriptions of the physical containers.

2. Certificates of Analysis (COA)

Every shipment must be backed by transparent, lot-specific Certificates of Analysis for both the raw materials and the finished product. A compliant COA cannot simply state “passed.” It must display the exact test methods used (e.g., HPLC, ICP-MS) and the numerical results for:

• Identity Testing: Proving the material matches its biological or chemical definition.
• Microbiological Limits: Confirming the absence or acceptable thresholds of pathogens (e.g., E. coli, Salmonella, total aerobic plate count, yeast, and mold).
• Heavy Metals Testing: Verifying compliance with strict limits for arsenic, cadmium, lead, and mercury.
• Contaminant Screening: Testing for residual pesticides, chemical solvents, or stability markers, where applicable.

3. Traceability and Stability Assets

The facility must provide clear batch and lot traceability documentation, demonstrating control from the raw material supplier down to the individual finished shipping carton. Additionally, real-time or accelerated stability data must be available to scientifically support the product’s declared shelf-life and expiration date under U.S. storage conditions.

Phase 7: The Foreign Supplier Verification Program (FSVP) Importer

For international companies, registering your facility with the FDA is only half the battle. Under the Food Safety Modernization Act (FSMA), the FDA enforces a strict mandatory guardrail for all imported foods and supplements: the Foreign Supplier Verification Program (FSVP).

What is the FSVP?

The FSVP rule requires that a U.S.-based entity take full legal liability for verifying that foreign food and supplement manufacturers are producing products using processes that provide the same level of public health protection required of domestic U.S. companies.

The FDA will no longer allow un-verified foreign cargo to simply land at a U.S. port. Every single dietary supplement entry filed with U.S. Customs must explicitly list the unique Dun & Bradstreet (DUNS) number of a designated FSVP Importer.

Who Can Act as the FSVP Importer?

The FSVP Importer must be a U.S. citizen, permanent resident, or a U.S. business entity located physically in the United States. It can be:

1. The actual U.S. owner or purchaser of the imported supplement cargo.
2. The U.S. agent or representative of the foreign owner, formally appointed in writing to act as the FSVP Importer.

Responsibilities of the FSVP Importer

The designated FSVP Importer cannot simply sign a paper and walk away. They are legally required to maintain a comprehensive FSVP dossier for each product and supplier, containing:

• • A formal hazard analysis evaluating the biological, chemical, or physical risks associated with the specific supplement.
  • An official performance evaluation of the foreign supplier, reviewing their FDA compliance history, warning letters, and country-level risks.

Supplier verification records: Ongoing documentation proving that the importer has reviewed the foreign factory’s cGMP certificates, batch records, and Certificates of Analysis

If the FDA conducts an FSVP audit on your U.S. importer and finds that they lack these records, the FDA will place the foreign manufacturer on an immediate Import Alert, blocking all future shipments from entering the country.

Phase 8: Import Readiness and Logistics Execution

Once your formulation is validated, your labels are engineered, your manufacturer records are organized, and your FSVP importer is appointed, you enter the operational logistics phase. To guarantee a smooth customs clearance, you must systematically execute the following steps:

1. FDA Foreign Facility Registration

Before your product leaves the exporting country, the physical manufacturing facility must be formally registered with the FDA via the Food Facility Registration (FFR) portal. This registration issues an official 11-digit FDA registration number. This number must be updated and renewed biennially during every even-numbered year.

2. Appointment of a U.S. Agent

Every foreign facility registration legally requires the appointment of a U.S. Agent. The U.S. Agent must be a physical resident or business entity located within the United States. This agent serves as the FDA’s primary point of contact for scheduling facility inspections, clarifying shipping errors, and handling emergency communications.

Note: The U.S. Agent for FDA facility registration and the FSVP Importer are two distinct legal roles with completely different liabilities, though a single qualified compliance firm can be retained to fulfill both functions.

3. Prior Notice Submission

For every individual shipment of dietary supplements heading to the United States, a Prior Notice must be filed electronically with the FDA before the cargo arrives at the port of entry. The Prior Notice provides the FDA with real-time tracking data, including the identity of the product, the manufacturing facility number, the shipper, and the anticipated arrival location. If a shipment arrives at a U.S. port without an approved Prior Notice confirmation number, the cargo is subject to immediate refusal and border containment.

Summary Checklist: The 19 Mandatory Technical Assets for U.S. Market Launch

Before authorizing production or booking international freight, verify that your export dossier contains every single one of the following technical deliverables:

Administrative & Registration Assets

• [ ] Active FDA Food Facility Registration (FFR) Number for the manufacturing plant.
• [ ] Formally signed U.S. Agent Appointment Agreement.
• [ ] Formal written appointment of the U.S.-based FSVP Importer.
• [ ] Complete corporate name and physical street address of the designated U.S. Distributor.

Formulation & Science Assets

• [ ] Complete, un-blinded quantitative formula listing every active ingredient and passive excipient down to the exact milligram or percentage concentration.
• [ ] Scientific botanical dossier detailing Latin binomials, precise plant parts used, extract ratios, and standardization markers for all herbal components.
• [ ] Regulatory assessment confirming the grandfathered status or formal NDI notification history of all dietary ingredients.
• [ ] Documented scientific substantiation file compiling peer-reviewed data supporting all structural/functional claims.

Laboratory & Quality Controls

• [ ] Certified, lot-specific Equilibrium pH Lab Report (via standard glass-electrode method).
• [ ] Certified Water Activity ($a_w$) Lab Report ensuring precise moisture limits.
• [ ] Raw material and finished product Certificates of Analysis (COA) displaying analytical test results for identity, microbiological safety, heavy metals, and target contaminants.
• [ ] Real-time or accelerated stability testing documentation validating the declared expiration date.

Packaging & Marketing Materials

• [ ] Final print-ready label artwork formatted in PDF layout including all side and back panels.
• [ ] Fully engineered U.S. Supplement Facts Panel compliant with 21 CFR 101.36.
• [ ] Compliant Other Ingredients statement incorporating clear allergen disclosures under FALCPA.
• [ ] Correctly positioned, bordered, and bolded DSHEA Disclaimer box adjacent to product claims.
• [ ] Copy of the intended website landing page, social media ad scripts, and promotional claims audited against FTC truth-in-advertising guidelines.

Manufacturing Plant Records

• [ ] Copy of the Master Manufacturing Record (MMR) used to run the production batch.
• [ ] Copy of the factory’s active third-party cGMP Certificate or latest independent facility audit report.

Secure Your Compliant Path to Market

The regulatory pathway for launching an imported dietary supplement in the United States leaves zero room for guesswork or administrative error. Navigating ingredient safety records, complex label formatting rules, and cross-border importer liabilities requires meticulous, specialized oversight.

At FDA Consults, we handle the heavy lifting of federal compliance, transforming complex regulatory demands into a clear, predictable journey. Let our team of regulatory specialists safeguard your investment, protect your supply chain, and ensure your brand enters the United States market with complete compliance and confidence.

🔹 Compliance Disclaimer FDA Consults is an independent consulting firm and is not affiliated with, endorsed by, or an official representative of the U.S. Food and Drug Administration or the Federal Trade Commission. The information provided in this manual is intended for educational and structural planning purposes and does not constitute formal legal representation. Final responsibility for continuous compliance, product safety, and claims.